Patents by Inventor Ben Waldman

Ben Waldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for regulation of chronic toxoplasma infection
    Patent number: 11945845
    Abstract: The present disclosure provides genetically altered protozoan parasites comprising a mutation in a bradyzoite formation deficient 1 (BFD1) gene, wherein the mutation inhibits differentiation of the parasite into a bradyzoite. The genetically altered protozoan parasites can be utilized in vaccine compositions and in methods of treating apicomplexan parasite infection.
    Type: Grant
    Filed: May 30, 2020
    Date of Patent: April 2, 2024
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Ben Waldman, Sebastian Lourido
  • Compositions and Methods for Regulation of Chronic Toxoplasma Infection
    Publication number: 20220235101
    Abstract: The present disclosure provides genetically altered protozoan parasites comprising a mutation in a bradyzoite formation deficient 1 (BFD1) gene, wherein the mutation inhibits differentiation of the parasite into a bradyzoite. The genetically altered protozoan parasites can be utilized in vaccine compositions and in methods of treating apicomplexan parasite infection.
    Type: Application
    Filed: May 30, 2020
    Publication date: July 28, 2022
    Inventors: Ben Waldman, Sebastian Lourido